Seeking Alpha

Mylan's (MYL +0.5%) subsidiary, Mylan Pharmaceuticals, has received final FDA approval for its...

Mylan's (MYL +0.5%) subsidiary, Mylan Pharmaceuticals, has received final FDA approval for its Modafinil Tablets, the generic version of Teva's (TEVA +0.2%) Provigil Tablets. The drug is designed to improve wakefulness in adult patients with narcolepsy, obstructive sleep apnea and shift work disorder.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|